TGA Approval

BIVALIRUDIN SXP bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (388791)

ARTG ID

388791

ARTG Name

BIVALIRUDIN SXP bivalirudin (as trifluoroacetate) 250 mg powder for injection vial

Sponsor

Southern XP IP Pty Ltd

ARTG Date

June 8, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Southern XP IP Pty Ltd

https://medical-cdn.nocode.com/drug_tga/2618fc70450f770f06e9ed9212603c17.pdf

https://medical-cdn.nocode.com/drug_tga/d7fb6bb0dff4445bc5bc999d6a49c73e.pdf

Ingredient Name

bivalirudin

Empowering clinical research with data-driven insights and AI-powered tools.

BIVALIRUDIN SXP bivalirudin (as trifluoroacetate) 250 mg powder for injection vial (388791) - TGA 批准文号 | MedPath